Ebola Virus Glycoprotein Mucin-Like Domain Replacement Expression System used as New Vaccine Approach
Development and evaluation of new vaccine approach against HIV-1 and other pathogens
Published: 9th June 2022

IP Status
- Patented
Seeking
- Development partner
- Commercial partner
- Licensing